News
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results